[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336034-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-336034-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","synchronous-versus-metachronous-spinal-metastasis-a-comparative-study-of-survival-outcomes-following-neurosurgical-treatment","Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment","","Patients with spinal metastases (SM) from solid tumors can present either concurrently with an established cancer diagnosis (metachronous SM) or as the first sign of an undiagnosed malignancy (synchronous SM). This study evaluates whether the timing of SM diagnosis changes prognosis after surgical resection. Survival after neurosurgical treatment was analyzed for 211 patients treated between 2015 and 2020.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/synchronous-versus-metachronous-spinal-metastasis-a-comparative-study-of-survival-outcomes-following-neurosurgical-treatment/336034/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/synchronous-versus-metachronous-spinal-metastasis-a-comparative-study-of-survival-outcomes-following-neurosurgical-treatment/336034.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What distinguishes synchronous from metachronous spinal metastases in the study?","Question",{"text":63,"@type":64},"Synchronous SM appears as the initial presentation of an undiagnosed malignancy, while metachronous SM develops concurrently with an existing cancer diagnosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was patient survival analyzed after neurosurgical treatment?",{"text":68,"@type":64},"Survival analysis started from the date of the neurosurgical procedure, comparing patients diagnosed with synchronous SM versus metachronous SM.",{"name":70,"@type":61,"acceptedAnswer":71},"Do the results show a survival difference between synchronous and metachronous SM after surgery?",{"text":72,"@type":64},"No. Median overall survival post-surgery was 13.5 months for synchronous SM versus 13 months for metachronous SM, with no statistically significant difference (p = 0.74).",{"name":74,"@type":61,"acceptedAnswer":75},"Which primary tumor types were most common among participants?",{"text":76,"@type":64},"The predominant primary tumors were lung cancer (23%), prostate cancer (21%), and breast cancer (11.3%).","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},336034,1790914568,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":120,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Journal of Cancer Research and Clinical Oncology (2024) 150:136  \n[https://doi.org/10.1007/s00432-024-05657-x](https://doi.org/10.1007/s00432-024-05657-x)  \nSynchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment  \nMohammed Banat1 · Anna‑Laura Potthoff1 · Motaz Hamed1 · Valeri Borger1 · Jasmin E. Scorzin1 · Tim Lampmann1 · Harun Asoglu1 · Logman Khalafov1 · Frederic C. Schmeel2 · Daniel Paech2 · Alexander Radbruch2 · Louisa Nitsch3 · Johannes Weller3 · Ulrich Herrlinger4 · Marieta Toma5 · Gerrit H. Gielen6 · Hartmut Vatter1 · Matthias Schneider1  \nReceived: 21 January 2024 / Accepted: 19 February 2024 / Published online: 19 March 2024 © The Author(s) 2024  \nAbstract  \nPurpose Patients with spinal metastases (SM) from solid neoplasms typically exhibit progression to an advanced cancer stage. Such metastases can either develop concurrently with an existing cancer diagnosis (termed metachronous SM) oremerge as the initial indication of an undiagnosed malignancy (referred to as synchronous SM). The present study investigates the prognostic implications of synchronous compared to metachronous SM following surgical resection.  \nMethods From 2015 to 2020, a total of 211 individuals underwent surgical intervention for SM at our neuro-oncology facility. We conducted a survival analysis starting from the date of the neurosurgical procedure, comparing those diagnosed with synchronous SM against those with metachronous SM.  \nResults The predominant primary tumor types included lung cancer (23%), prostate cancer (21%), and breast cancer (11.3%) . Of the participants, 97 (46%) had synchronous SM, while 114 (54%) had metachronous SM. The median overall survival post-surgery for those with synchronous SM was 13.5 months (95% confidence interval (CI) 6.1–15.8) compared to 13 months (95% CI 7.7–14.2) for those with metachronous SM (p = 0.74) .  \nConclusions Our findings suggest that the timing of SM diagnosis (synchronous versus metachronous) does not significantly affect survival outcomes following neurosurgical treatment for SM. These results support the consideration of neurosurgical procedures regardless of the temporal pattern of SM manifestation.  \nKeywords Surgery for spinal metastasis · Synchronous versus metachronous tumor occurrence · Survival · Neuro-oncology  \nAbbreviations  \nASA American Society of Anesthesiologists ASIA American Spinal Injury Association CCI Charlson Comorbidity Index  \n* Mohammed Banat [Mohammed.Banat@ukbonn.de](Mohammed.Banat@ukbonn.de)  \n1 Department of Neurosurgery, University Hospital Bonn, Venusberg-Campus 1, Building 81, 53127 Bonn, Germany  \n2 Department of Neuroradiology, University Hospital Bonn, Bonn, Germany  \n3 Department of Neurology, University Hospital Bonn, 53127 Bonn, Germany  \n4 Division of Clinical Neuro-Oncology, Department of Neurology, University Hospital Bonn, Bonn, Germany  \n5 Institute of Pathology, University Hospital Bonn, Bonn, Germany  \n6 Institute for Neuropathology, University Hospital Bonn, Bonn, Germany  \nCI Confidence interval  \nKPS Karnofsky Performance Scale SM Spinal metastases  \nOS Overall survival  \nIntroduction  \nSystemic tumor disease with singular or multiple spinal metastases (SM) has assumed an increasingly prominent role in the daily clinical practice of spine surgeons and the lives of affected patients (Coleman 2006 ; Brande et al. 2022) . It is estimated that approximately 5–15% of all cancer patients will ultimately develop spinal metastases (Brande et al. 2022 ; Jenis et al. 1999 ; Jacobs and Perrin 2001) . Among the primary culprits are breast cancer, prostate cancer, and lung cancer, with the primary tumor remaining elusive in 3–10% of cases (Greenlee et al. 2000 ; Ulmar et al. 2007) .  \nIn the therapeutic arsenal for this profoundly affected patient population, surgery stands as a common treatment modality (Furlan et al. 2022) . After lungs and liver, skeletal system and bones bear the brunt o","cbCait1VlUWVn7NK","https://ap.wps.com/l/cbCait1VlUWVn7NK","pdf",608118,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Clinical background and treatment options","[{\"question\":\"What distinguishes synchronous from metachronous spinal metastases in the study?\",\"answer\":\"Synchronous SM appears as the initial presentation of an undiagnosed malignancy, while metachronous SM develops concurrently with an existing cancer diagnosis.\"},{\"question\":\"How was patient survival analyzed after neurosurgical treatment?\",\"answer\":\"Survival analysis started from the date of the neurosurgical procedure, comparing patients diagnosed with synchronous SM versus metachronous SM.\"},{\"question\":\"Do the results show a survival difference between synchronous and metachronous SM after surgery?\",\"answer\":\"No. Median overall survival post-surgery was 13.5 months for synchronous SM versus 13 months for metachronous SM, with no statistically significant difference (p = 0.74).\"},{\"question\":\"Which primary tumor types were most common among participants?\",\"answer\":\"The predominant primary tumors were lung cancer (23%), prostate cancer (21%), and breast cancer (11.3%).\"}]","Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment | PDF",1790013298,23]